SecBot SecBot
425 ·Filed Jul 8, 2026

NHIC

NewHold Investment Corp. III
NEUTRAL
Impact 5/10
Horizonmonths Processed3mo ago SEC0001213900-26-076182
Rule 425 M&A communications
Actionable Insight • Neutral

The F-4 filing is a procedural step forward, but the deal remains subject to shareholder vote and SEC review. Monitor for redemptions and any amendments to the F-4 that could signal changes in terms or investor sentiment. The key catalyst will be the shareholder meeting and SEC effectiveness.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d
NHIC ▼ -1.75% at T+20d
NEUTRAL call -1.75% · α vs SPY -5.02% · entry $10.87 → $10.68
Next anchor: T+60d due 27d ago
Entry = T+0 close
Jul 8, 2026
via day close
T+1d
+0.46%
call +0.46% · α -0.39%
$10.92
settled 4mo ago
T+5d
-1.01%
call -1.01% · α -1.87%
$10.76
settled 4mo ago
T+20d
-1.75%
call -1.75% · α -5.02%
$10.68
settled 3mo ago
T+60d
Pending
due 27d ago

Price Chart

Loading chart...

Executive Summary

NewHold Investment Corp. III (NHIC) announced that newcleo Ltd. filed an F-4 registration statement with the SEC in connection with their proposed business combination. The filing is a procedural milestone that provides a preliminary proxy/prospectus for shareholder review. The deal is expected to close in the second half of 2026, subject to shareholder approval, SEC effectiveness, and other customary conditions.

Key Financial Metrics

Deal Value
$2.4B
Deal Type
merger

Key Facts

  • Newcleo filed an F-4 registration statement (preliminary proxy/prospectus) with the SEC on July 6, 2026.
  • The proposed business combination is expected to close in the second half of 2026, subject to shareholder approval, SEC effectiveness, and other customary closing conditions.
  • The combined company will operate as newcleo plc and list on Nasdaq under the ticker NWCL.
  • Up to $429 million in gross proceeds expected: $220 million from PIPE and up to $209 million from NewHold's trust account (before redemptions and expenses).
  • Newcleo reported over $80 million in revenue, other income and financial income in 2024, and over $780 million in private funding.

Financial Impact

Up to $429 million in gross proceeds for newcleo from the business combination, combining $220 million PIPE and up to $209 million in trust cash (pre-redemption).

cashequity_value

Risk Factors

  • Shareholder redemptions could reduce the trust cash available to the combined company.
  • SEC review may delay or require changes to the proxy/prospectus.
  • Failure to obtain shareholder approval could scuttle the deal.
  • Regulatory approvals for nuclear technology and cross-border operations remain uncertain.

Market Snapshot

Exchange
Nasdaq
Sector
Blank Checks

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001213900-26-076182
Document: 0001213900-26-076182-index-headers.html0001213900-26-076182
Document: 0001213900-26-076182-index.html0001213900-26-076182
Document: 0001213900-26-076182.txt0001213900-26-076182
3 reports for NHIC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NHIC — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
25-NSE
BEARISH ★ 7/10
$8.66awaiting T+5——
Sep 11, 2026
6w ago
425 / 8-K
BULLISH ★ 6/10
$10.64 $8.67▼ −18.52%▼ −18.29%—
Jul 8, 2026
15w ago
425
NEUTRAL ★ 5/10
$10.87 $10.76▼ −1.01%▼ −1.87%—
Showing 3 of 3

US Market Status

Market Closed — Opens Thu (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 8, 2026